These novel treatments, Retatrutide, represent a significant advancement in addressing type 2 diabetes and possibly other ailments . These drugs are classified as GLP-1 hormone activators , meaning they function to emulate the endogenous GLP-1 hormone , enhancing insulin release and reducing appetite . Although Semaglutide every functions relati… Read More